GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (STU:2RH) » Definitions » Accounts Payable

Redhill Biopharma (STU:2RH) Accounts Payable : €7.51 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Redhill Biopharma Accounts Payable?

Redhill Biopharma's Accounts Payable for the quarter that ended in Dec. 2024 was €7.51 Mil.

Redhill Biopharma's quarterly Accounts Payable declined from Dec. 2023 (€3.01 Mil) to Jun. 2024 (€1.78 Mil) but then increased from Jun. 2024 (€1.78 Mil) to Dec. 2024 (€7.51 Mil).

Redhill Biopharma's annual Accounts Payable declined from Dec. 2022 (€3.99 Mil) to Dec. 2023 (€3.01 Mil) but then increased from Dec. 2023 (€3.01 Mil) to Dec. 2024 (€7.51 Mil).


Redhill Biopharma Accounts Payable Historical Data

The historical data trend for Redhill Biopharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Accounts Payable Chart

Redhill Biopharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.50 10.32 3.99 3.01 7.51

Redhill Biopharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.08 2.87 3.01 1.78 7.51

Redhill Biopharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Redhill Biopharma Accounts Payable Related Terms

Thank you for viewing the detailed overview of Redhill Biopharma's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Redhill Biopharma Business Description

Traded in Other Exchanges
Address
21 Ha’arba’a Street, Tel Aviv, ISR, 6473921
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Redhill Biopharma Headlines

No Headlines